Inglis Tiffany Eul Davis sold $728 of SERA
Inglis Tiffany Eul Davis (Chief Medical Officer) sold 362 shares of SERA PROGNOSTICS, INC. (SERA) at $2.01 on 2026-06-11.
How this was made
The 30-second read
Why it matters
An officer (Chief Medical Officer) executed an open-market sale; the filing provides transparency on insider behavior but does not include operational or financial performance updates.
Market read
This is a disclosed insider sale; it may slightly affect sentiment but lacks fundamental catalysts in the text.
What to watch
Traders may want to compare with prior insider transactions, total insider ownership, and whether other executives/owners are selling or buying around the same window.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for SERA PROGNOSTICS, INC.
Ticker impact
SEC Form 4 shows CMO Inglis Tiffany Eul Davis sold 362 shares of SERA at $2.01/share on 2026-06-11.
Likely minimal near-term price impact; watch for follow-on insider activity or unusual volume.
The filing is a small, disclosed sale by an officer with no stated 10b5-1 plan, but insider sales alone rarely drive material repricing without corroborating fundamentals.
Market effects
No sector-level implications; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Absence of a pre-arranged 10b5-1 plan could be interpreted as less “mechanical,” but the disclosed size is still small and may not reflect fundamentals.
Key entities
- issuerSERA PROGNOSTICS, INC.
Company whose insider transaction is disclosed on Form 4.
- insiderInglis Tiffany Eul Davis
Chief Medical Officer who sold 362 shares at $2.01/share.
